Similar articles

• Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).

  FRIEDMAN AP, LOSIN S. FRIEDMAN AP, et al. Arch Neurol. 1961 Mar;4:241-5. doi: 10.1001/archneur.1961.00450090007002. Arch Neurol. 1961. PMID: 13701987 No abstract available.
• The serotonin antagonist 1-methyl-D-lysergic acid butanolamine (UML-491) or methysergide ('Deseril'), its pharmacodynamics and effects on 'migraine type' vascular headaches.

  LEIGH WE. LEIGH WE. S Afr Med J. 1963 Jun 15;37:631-7. S Afr Med J. 1963. PMID: 13929429 No abstract available.
• Clinical observations with 1-methyl-lysergic acid butanolamide (UML-491) in vascular headache.

  FRIEDMAN AP. FRIEDMAN AP. Angiology. 1960 Aug;11:364-6. doi: 10.1177/000331976001100409. Angiology. 1960. PMID: 13825096 No abstract available.
• [THERAPEUTICS IN 1963].

  PERRAULT M, DRY J. PERRAULT M, et al. Rev Prat. 1963 Dec 21;13:3925-77. Rev Prat. 1963. PMID: 14100436 Review. French. No abstract available.
• NEWER DRUGS IN THE TREATMENT OF HEADACHE.

  FRIEDMAN AP. FRIEDMAN AP. Med Clin North Am. 1964 Mar;48:445-57. doi: 10.1016/s0025-7125(16)33475-7. Med Clin North Am. 1964. PMID: 14149244 Review. No abstract available.